Psychoactive drugs alter consciousness by disrupting the way brain cells communicate with each other. They change the chemical signals neurons use to send and receive information, which shifts your mood, perception, sense of time, and awareness of yourself and your surroundings. The specific changes depend on the type of drug, the dose, and your individual brain chemistry, but all psychoactive substances work by hijacking the same basic signaling systems your brain uses every day.
How Brain Signaling Gets Disrupted
Your brain runs on chemical messengers called neurotransmitters. Every thought, sensation, and emotion involves neurons releasing these chemicals to communicate with neighboring cells. Psychoactive drugs interfere with this process in a few distinct ways.
Some drugs mimic the shape of natural neurotransmitters so closely that they can activate neurons directly. Marijuana and heroin both work this way, slotting into receptors that normally respond to the brain’s own chemicals. Others, like cocaine and amphetamines, force neurons to flood the gaps between cells with far more neurotransmitter than normal, or they block the recycling process that would normally clear those chemicals away. The result is an amplified, distorted version of signals your brain already produces.
Dopamine plays a central role across nearly all drug-induced changes in consciousness. It’s the neurotransmitter most closely tied to the brain’s reward system, and surges of dopamine (along with the body’s natural opioids, endorphins) drive the euphoria or “high” that most psychoactive substances produce. But different drug classes push consciousness in very different directions depending on which additional systems they target.
Stimulants: Heightened Focus and Warped Time
Stimulants like amphetamines and cocaine ramp up dopamine and norepinephrine activity, producing a state of heightened arousal, sharpened attention, and often intense euphoria. Your brain enters a mode of increased alertness where thoughts feel faster and more focused. With oral amphetamine, subjective effects typically begin within 30 minutes and peak somewhere between 60 and 90 minutes after ingestion, though there’s significant individual variation. Roughly half of people in controlled studies peak after the 60-minute mark, about a quarter peak earlier, and 20 to 30 percent don’t report a noticeable subjective response at all. People who feel effects earlier also tend to absorb the drug into their bloodstream faster.
One of the more interesting effects on consciousness involves time perception. People with lower baseline dopamine levels tend to have a compressed sense of time, perceiving durations as shorter than they actually are. When dopamine availability in the frontal brain regions increases, time perception measurably improves. In one study, boosting frontal dopamine improved accuracy in estimating time intervals ranging from 5 to 60 seconds. This may partly explain why stimulants can make minutes feel like they stretch out, or why focused tasks seem to expand in duration.
Depressants: Dampened Awareness
Alcohol, benzodiazepines, and sedatives move consciousness in the opposite direction. They enhance the activity of GABA, the brain’s primary inhibitory neurotransmitter. GABA’s job is to quiet neural firing, and when drugs amplify its effects, the result is reduced arousal, slower processing, and a general dimming of awareness. At low doses this feels like relaxation and lowered inhibition. At higher doses, it progresses to drowsiness, impaired coordination, and eventually unconsciousness.
A specific set of GABA receptors located outside the main communication points between neurons are especially important for regulating consciousness. These receptors create a constant, low-level background of neural inhibition, like a volume knob for overall brain activity. Anesthetics, sleep-promoting drugs, alcohol, and certain hormones produced during stress all target these same receptors. This is why depressants don’t just change the content of consciousness (what you think about) but reduce its overall level (how awake and aware you are). Opioids like heroin add another layer by disrupting the brainstem, which controls heart rate, breathing, and sleep cycles, making overdose especially dangerous.
Psychedelics: Rewiring Perception
Psychedelics produce the most dramatic and complex changes in consciousness. Substances like psilocybin (the active compound in magic mushrooms), LSD, and mescaline induce profound shifts in perception, emotion, and cognition. Colors intensify, boundaries between the self and the environment blur, and thought patterns become fluid and unconstrained. At sufficient doses, people report what researchers classify as “complete mystical experiences,” including a sense of unity, transcendence of time and space, and deep emotional significance.
These effects depend on activation of a specific type of serotonin receptor. While psychedelics bind to multiple receptor types (LSD, for instance, also interacts with dopamine and adrenaline receptors), the serotonin receptor activation is the necessary ingredient for hallucinogenesis. What makes psychedelics unique is not simply that they activate this receptor, but how they activate it. They trigger a distinct internal signaling pathway that non-hallucinogenic compounds targeting the same receptor do not. This difference in signaling, rather than the receptor itself, appears to be what generates the hallucinatory experience.
Dose matters considerably. With psilocybin, even very small amounts produce measurable changes in consciousness scores on standardized scales. But complete mystical experiences, the kind associated with lasting psychological impact, typically require doses of roughly 350 micrograms per kilogram of body weight or higher. Lower doses in the range of 100 to 150 micrograms per kilogram produce milder perceptual shifts without the full dissolution of ordinary self-awareness.
What Brain Scans Reveal
Neuroimaging studies have identified a consistent pattern in how psychedelics reshape brain activity. The brain has a set of interconnected regions called the Default Mode Network that is most active during self-referential thinking: daydreaming, recalling memories, planning for the future, and maintaining your sense of identity. Under psychedelics, communication within this network drops significantly while connections between brain regions that don’t normally talk to each other increase.
LSD reduces activity across three major hubs of this network spanning five different frequency bands of brain oscillation. Psilocybin similarly decreases connectivity within the network while boosting global brain connectivity. In one study, out of over 35,000 possible connections measured, 695 were significantly different from baseline after psilocybin administration. Key nodes that normally work together to maintain your sense of “self” become decoupled from each other.
This pattern, reduced internal organization combined with increased cross-talk between networks, maps neatly onto what people report feeling. The weakening of the Default Mode Network correlates with ego dissolution: the sensation that the boundary between “you” and the rest of the world is thinning or disappearing. Meanwhile, the surge in novel connections between brain regions may explain the unusual associations, synesthesia (hearing colors, seeing sounds), and creative or bizarre thought patterns that characterize the psychedelic state.
The Tradeoff Between Flexibility and Clarity
One framework for understanding these changes comes from integrated information theory, which attempts to explain consciousness in mathematical terms. Applied to psychedelic brain imaging data, this framework suggests that drugs like psilocybin and LSD enhance cognitive flexibility, creativity, and imagination, but at a real cost. The brain’s ability to organize, categorize, and differentiate the building blocks of conscious experience degrades. You gain unconstrained cognition and a feeling of expanded awareness, but lose the structured information processing that lets you make sharp distinctions between concepts and experiences.
This tradeoff helps explain why psychedelic states feel simultaneously more expansive and less coherent than ordinary consciousness. The sense of profound meaning coexists with an inability to pin that meaning down in precise terms. It also suggests that the “expanded” consciousness people report isn’t simply “more” consciousness. It’s a reorganized form where the usual constraints are loosened, allowing novel patterns to emerge while sacrificing the cause-and-effect clarity that normally structures your mental life.
Therapeutic Interest in Altered States
The ability of psychoactive drugs to reshape consciousness is now being actively studied as a treatment tool. As of May 2024, 278 clinical trials had been registered for classic psychedelics, MDMA, and related compounds. Psilocybin alone accounted for over 134 registered trials exploring 54 different potential uses, from depression to addiction to end-of-life anxiety. Some of these trials have reported large effect sizes, substantially larger than those seen with standard antidepressants (which typically show a small effect size of around 0.3).
However, these results come with important caveats. Most psychedelic therapy trials are small, and it’s nearly impossible to truly blind participants to whether they received a powerful consciousness-altering drug or a placebo. This “functional unblinding” likely inflates the apparent benefits. The trials also tend to be designed in highly controlled, explanatory settings that may not reflect what would happen in broader real-world use. The therapeutic promise is real but still being carefully tested, and the large effect sizes reported early on will likely shrink as studies get larger and more rigorous.